Patent Assignment
Reel/Frame 021291/0605
GRANT OF SECURITY INTEREST
Recorded: 2008-07-25
Received: 2008-07-25
Pages: 18
Assignor
NANOGEN, INC.
Executed: 2008-03-27
Assignee
PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
C/O RAMIUS CAPITAL GROUP, L.L.C., 666 THIRD AVENUE, 26TH FLOOR, NEW YORK, NY, 10017, UNITED STATES
Covered Applications
(100)
MESOPOROUS PERMEATION LAYERS FOR USE ON ACTIVE ELECTRONIC MATRIX DEVICES
App. No. 11/855,374
→
PROGRAMMABLE MULTIPLEXED ACTIVE BIOLOGIC ARRAY
App. No. 11/852,826
→
Fluorescent Cartridge for Calibration of a Microarray Reader
App. No. 11/847,991
→
COMPOSITIONS AND METHODS FOR PRESERVING PERMEATION LAYERS FOR USE ON ACTIVE ELECTRONIC MATRIX DEVICES
App. No. 11/846,187
→
Methods for Rapid, Single-Step Strand Displacement Amplification of Nucleic Acids
App. No. 11/838,024
→
Differential Immunoassay
App. No. 11/751,537
→
Methods for predicting outcome in traumatic brain injury
App. No. 11/737,561
→
Diagnostic methods for congestive heart failure
App. No. 11/786,885
→
SELF-ADDRESSABLE SELF-ASSEMBLING MICROELECTRONIC INTEGRATED SYSTEMS, COMPONENT DEVICES, MECHANISMS, METHODS, AND PROCEDURES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS
App. No. 11/726,520
→
INTEGRATED PORTABLE BIOLOGICAL DETECTION SYSTEM
App. No. 11/702,417
→
SELF-ADDRESSABLE SELF-ASSEMBLING MICROELECTRONIC SYSTEMS AND DEVICES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS
App. No. 11/702,353
→
MULTIPLEXED ACTIVE BIOLOGIC ARRAY
App. No. 11/639,688
→
THREE DIMENSIONAL DIELECTROPHORETIC SEPARATOR AND METHODS OF USE
App. No. 11/638,093
→
Conjunctive analysis of biological marker expression for predicting cardiac mortality
App. No. 11/600,967
→
PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES
App. No. 11/580,470
→
PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF INSULIN RESISTANCE
App. No. 11/517,095
→
Apolipoprotein biopolymer marker indicative of normal human
App. No. 11/516,850
→
COMPLEMENT C3 PRECURSOR BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/517,216
→
COMPLEMENT C3 PRECURSOR BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES
App. No. 11/503,787
→
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
App. No. 11/485,905
→
Method for detecting large mutations and duplications using control amplification comparisons to paralogous genes
App. No. 11/485,167
→
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
App. No. 11/440,809
→
FIBRONECTIN AND FIBRINOGEN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,814
→
FIBRONECTIN AND FIBRINOGEN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,556
→
INTERALPHA TRYPSIN INHIBITOR BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,587
→
PROTEIN BIOPOLYMER MARKERS INDICATIVE OF AGE MATCHED CONTROL
App. No. 11/439,590
→
FIBRONECTIN AND FIBRINOGEN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,813
→
FIBRONECTIN AND FIBRINOGEN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,577
→
PROTEIN BIOPOLYMER MARKERS INDICATIVE OF AGE MATCHED CONTROL
App. No. 11/439,586
→
INTERALPHA TRYPSIN INHIBITOR BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 11/439,588
→
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
App. No. 11/437,969
→
PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF INSULIN RESISTANCE
App. No. 11/437,918
→
DIAGNOSTIC DEVICE
App. No. 10/531,912
→
Methods for the electronic, homogeneous assembly and fabrication of devices
App. No. 11/401,713
→
POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PROBNP
App. No. 11/375,432
→
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
App. No. 11/351,462
→
Process for retarding phagocytosis of astrocytic cells
App. No. 11/351,997
→
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
App. No. 11/351,461
→
BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 1077 DALTONS
App. No. 11/291,804
→
Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
App. No. 11/251,229
→
Protein biopolymer markers predictive of alzheimer's disease
App. No. 11/243,332
→
BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 1525 DALTONS
App. No. 11/241,443
→
BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 1424 DALTONS
App. No. 11/241,434
→
METHODS AND MATERIALS FOR OPTIMIZATION OF ELECTRONIC TRANSPORTATION AND HYBRIDIZATION REACTIONS
App. No. 11/234,054
→
ELECTRODE BASED PATTERNING OF THIN FILM SELF-ASSEMBLED NANOPARTICLES
App. No. 11/233,486
→
Microstructure apparatus and method for separating differently charged molecules using an applied electric field
App. No. 11/175,195
→
Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
App. No. 11/170,514
→
METHOD AND KIT FOR DIAGNOSING MYOCARDIAL INFARCTION
App. No. 11/144,402
→
Nanoscale electronic detection system and methods for their manufacture
App. No. 11/140,555
→
MESOPOROUS PERMEATION LAYERS FOR USE ON ACTIVE ELECTRONIC MATRIX DEVICES
App. No. 11/082,325
→
MULTIPLEXED ACTIVE BIOLOGIC ARRAY
App. No. 11/081,123
→
Charged permeation layers for use on active electronic matrix devices
App. No. 11/044,739
→
Permeation layer attachment chemistry and method
App. No. 11/022,200
→
Microtiter plate format device and methods for separating differently charged molecules using an electric field
App. No. 10/980,821
→
Primer extension detection methods on active electronic microarrays
App. No. 10/942,565
→
ELECTRONIC SYSTEMS AND COMPONENT DEVICES FOR MACROSCOPIC AND MICROSCOPIC MOLECULAR BIOLOGICAL REACTION, ANALYSES, AND DIAGNOSTICS
App. No. 10/925,375
→
METHOD FOR DIAGNOSING AND DISTINGUISHING STROKE AND DIAGNOSTIC DEVICES FOR USE THEREIN
App. No. 10/924,283
→
Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
App. No. 10/772,744
→
ADDRESSABLE BIOLOGIC ELECTRODE ARRAY
App. No. 10/764,041
→
Differential immunoassay
App. No. 10/673,781
→
METHODS AND APPARATUS FOR SCREENING AND DETECTING MULTIPLE GENETIC MUTATIONS
App. No. 10/627,950
→
Method for identification of glycosylated polypeptides
App. No. 10/461,004
→
Anchored strand displacement amplification on an electronically addressable microchip
App. No. 10/387,304
→
MONOCLONAL ANTIBODIES AGAINST N-TERMINUS PROBNP
App. No. 10/359,046
→
CALIBRATOR FOR NT-PROBNP IMMUNOASSAY
App. No. 10/359,028
→
METHODS FOR THE ELECTRONIC, HOMOGENEOUS ASSEMBLY AND FABRICATION OF DEVICES
App. No. 10/337,450
→
METHOD FOR RETARDING OR PRECLUDING ALZHEIMER'S DEMENTIA
App. No. 10/334,701
→
Method of confirming the presence of myocardial infarction
App. No. 10/325,162
→
PROCESS FOR DETERMINING THE PRESENCE OF MONOMERIC BRAIN ASSOCIATED HUMAN GLUTAMINE SYNTHETASE IN PATIENTS EXHIBITING MILD COGNITIVE IMPAIRMENT
App. No. 10/246,383
→
METHODS FOR DETERMINATION OF SINGLE NUCLEIC ACID POLYMORPHISMS USING A BIOELECTRONIC MICROCHIP
App. No. 10/245,206
→
AMINO ACID SEQUENCE PATTERN MATCHING
App. No. 10/231,660
→
PROGRAMMABLE MULTIPLEXED ACTIVE BIOLOGIC ARRAY
App. No. 10/224,750
→
INTEGRATED PORTABLE BIOLOGICAL DETECTION SYSTEM
App. No. 10/163,835
→
BIOLOGIC ELECTRODE ARRAY WITH INTEGRATED OPTICAL DETECTOR
App. No. 10/143,036
→
MULTIPLEXED ACTIVE BIOLOGIC ARRAY
App. No. 10/143,037
→
METHODS AND APPARATUS FOR DETECTING VARIANTS UTILIZING BASE STACKING
App. No. 10/108,280
→
DIELECTROPHORETIC SEPARATION AND IMMUNOASSAY METHODS ON ACTIVE ELECTRONIC MATRIX DEVICES
App. No. 10/072,660
→
MESOPOROUS PERMEATION LAYERS FOR USE ON ACTIVE ELECTRONIC MATRIX DEVICES
App. No. 10/014,895
→
HYBRIDIZATION OF POLYNUCLEOTIDES CONJUGATED WITH CHROMOPHORES AND FLUOROPHORES TO GENERATE DONOR-TO-DONOR ENERGY TRANSFER SYSTEM
App. No. 09/997,374
→
Complement C3 precursor biopolymer markers related to Alzheimer's Disease
App. No. 09/994,909
→
FIBRONECTIN PRECURSOR BIOPOLYMER MARKERS INDICATIVE OF ALZHEIMER'S DISEASE
App. No. 09/993,289
→
IG HEAVY CHAIN, IG KAPPA, IG LAMBDA BIOPOLYMER MARKERS PREDICTIVE OF ALZHEIMER'S DISEASE
App. No. 09/993,304
→
COMPLEMENT C3 PRECURSOR BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES
App. No. 09/993,287
→
Glycoprotein and apolipoprotein biopolymer markers indicative of Alzheimer's disease
App. No. 09/993,344
→
HP BIOPOLYMER MARKERS PREDICTIVE OF INSULIN RESISTANCE
App. No. 09/991,800
→
Cene-E biopolymer marker indicative of age matched control
App. No. 09/993,399
→
BIOPOLYMER MARKERS INDICATIVE OF TYPE II DIABETES
App. No. 09/993,300
→
PROTEIN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 09/993,392
→
FIBRONECTIN BIOPOLYMER MARKER INDICATIVE OF INSULIN RESISTANCE
App. No. 09/993,365
→
PROTEIN BIOPOLYMER MARKERS INDICATIVE OF ALZHEIMER'S DISEASE
App. No. 09/992,672
→
COMPLEMENT C3 PRECURSOR BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 09/993,290
→
IG LAMBDA BIOPOLYMER MARKERS PREDICTIVE OF ALZHEIMERS DISEASE
App. No. 09/991,797
→
PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES
App. No. 09/993,393
→
FRAGMENT OF PLASMA PROTEASE C1 INHIBITOR
App. No. 09/991,799
→
FIBRONECTIN BIOPOLYMER MARKERS INDICATIVE OF TYPE II DIABETES
App. No. 09/991,796
→
PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF INSULIN RESISTANCE
App. No. 09/991,627
→
INTER-ALPHA TRYPSIN INHIBITOR BIOPOLYMER MARKER INDICATIVE OF INSULIN RESISTANCE
App. No. 09/993,295
→
BETAINE/GABA TRANSPORT PROTEIN BIOPOLYMER MARKER INDICATIVE OF INSULIN RESISTANCE
App. No. 09/992,067
→
APOLIPOPROTEIN BIOPOLYMER MARKERS INDICATIVE OF INSULIN RESISTANCE
App. No. 09/993,366
→
POWER SUPPLY CIRCUIT WITH A SOFT STARTING CIRCUIT
App. No. 09/979,086
→